中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2015 No. 9

Display Method:
Editorial
Progress in immunotherapy and molecular therapy for liver failure
Xi Dong, Ning Qin
2015, 31(9): 1369-1371. DOI: 10.3969/j.issn.1001-5256.2015.09.001
Abstract:

Liver failure is a complex process involving many factors. The molecular therapy targeting the cytokines and receptors associated with liver failure has become the research hotspots in recent years. Immunotherapy for liver failure includes promoting the regeneration of hepatocytes and immunoregulati...

Therapeutic guidelines
Guidelines for application of tacrolimus in clinical liver transplantation
Chinese Society of Organ TransplantationChinese Medical Association;
2015, 31(9): 1372-1374. DOI: 10.3969/j.issn.1001-5256.2015.09.002
Abstract:
Guidelines for the management of pancreatic cystic lesions(2015)
Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Associati
2015, 31(9): 1375-1378. DOI: 10.3969/j.issn.1001-5256.2015.09.003
Abstract:
Recommendation about hepatitis C guidance: AASLD-IDSA recommendations for testing managing, and treating adults infected with hepatitis C virus
Jiang Yong, Han Tao
2015, 31(9): 1379-1383. DOI: 10.3969/j.issn.1001-5256.2015.09.004
Abstract:
Elastography assessment of liver fibrosis :society of radiologists in ultrasound consensus conference statement
Hou FeiFei, Qi XingShun, Guo XiaoZhong
2015, 31(9): 1384-1388. DOI: 10.3969/j.issn.1001-5256.2015.09.005
Abstract:
Recommendations for 2014 APA guidelines for the diagnosis and treatment of chronic pancreatitis
Wang YaJun, Cao Feng, Sun JiaBang
2015, 31(9): 1389-1391. DOI: 10.3969/j.issn.1001-5256.2015.09.006
Abstract:
Discussions by experts
Hotspots and management strategies for liver failure diagnosis and treatment
Shi GuangFeng, Huang Chong
2015, 31(9): 1392-1395. DOI: 10.3969/j.issn.1001-5256.2015.09.007
Abstract:

Liver failure is a threat to human health. The survival of patients has been increased with the improvement in both diagnosis and treatment. Several major advances in the diagnosis and treatment of liver failure have been made in recent years,as follows: the EASL-defined diagnostic criteria for acut...

Management and prevention of invasive fungal disease in liver failure
Nie QingHe, Yang Jie
2015, 31(9): 1396-1399. DOI: 10.3969/j.issn.1001-5256.2015.09.008
Abstract:

Liver failure is a clinical critical illness,and its complications have various clinical manifestations,often resulting in local or systemic invasive fungal disease( IFD). The damage of other organs may occur secondary to IFD in liver failure patients,thus worsening liver injury. This will ultimatel...

Current Research on acute-on-chronic liver failure: a comparison between Eastern and Western countries
Zheng SuJun, Duan ZhongPing
2015, 31(9): 1400-1404. DOI: 10.3969/j.issn.1001-5256.2015.09.009
Abstract:

Acute-on-chronic liver failure( ACLF) is the most complicated form of liver failure among various types of liver failure. There are certain differences in the conception,etiology,and pathogenesis of ACLF between different regions. In recent years,ACLF has attracted attention of hepatologists all ove...

Application of artificial liver support system in treatment of liver failure
Yang JianLe, Huang JianRong
2015, 31(9): 1405-1410. DOI: 10.3969/j.issn.1001-5256.2015.09.010
Abstract:

Liver failure is a common clinical syndrome of serious liver disease with high fatality. Artificial liver support system is one of the effective methods in the treatment of liver failure,which is widely used by clinicians as a common treatment method for liver failure. This article reviews the princ...

Clinical efficacy and problems of artificial liver support system in treatment of liver failure
Zheng HuanWei, Li Li, Bai GeLan
2015, 31(9): 1411-1414. DOI: 10.3969/j.issn.1001-5256.2015.09.011
Abstract:

Liver failure is a common pathophysiological process of various hepatic diseases developing into the end stage. Because of its intricate pathogenesis and lack of specific and impactful treatment,the incidence and mortality of hepatic failure remains high and life-threatening. Currently,the principle...

Acute-on-chronic liver failure due to bacterial infection in liver cirrhosis: causes and management
Han Tao
2015, 31(9): 1415-1417. DOI: 10.3969/j.issn.1001-5256.2015.09.012
Abstract(2852) PDF (154KB)(586)
Abstract:

Bacterial infection is a common complication in patients with liver cirrhosis,and acute-on-chronic liver failure due to bacterial infection has become a serious clinical problem. There are still many problems in the research on the pathogenesis and management of bacterial infection in liver cirrhosi...

Original articles_Liver failure and artificial liver support system
The predictive values of four scoring systems in short-term prognosis of patients with hepatitis B-associated acute-on-chronic liver failure
Liu Huan, Song LiWen, Cao WuKui, Li Fei
2015, 31(9): 1418-1421. DOI: 10.3969/j.issn.1001-5256.2015.09.013
Abstract:

Objective To investigate the predictive values of four scoring systems,the Model for End-Stage Liver Disease( MELD),the MELD with incorporation of serum sodium( MELD-Na),the integrated MELD( i MELD),and the MELD to serum sodium ratio( MESO),in the short-term prognosis of patients with hepatitis B-as...

An analysis of predictive factors for concurrent acute-on-chronic liver failure and hepatorenal syndrome
Chen YanFang, Zhang YongBiao, Liang CaiQian
2015, 31(9): 1422-1425. DOI: 10.3969/j.issn.1001-5256.2015.09.014
Abstract:

Objective To learn the clinical characteristics of concurrent acute-on-chronic liver failure( ACLF) and hepatorenal syndrome( HRS),and to investigate the predictive factors for HRS in patients with ACLF. Methods A total of 806 patients with ACLF who were admitted to our hospital from January 2012 to...

Clinical efficacy of modulation of intestinal microecology and plasmapheresis for preventing and treating multiple organ failure in patients with severe hepatitis
Wang QingHai, Tian Yi
2015, 31(9): 1426-1429. DOI: 10.3969/j.issn.1001-5256.2015.09.015
Abstract:

Objective To explore the methods for prevention and treatment of endotoxemia and multiple organ failure in patients with severe hepatitis. Methods A total of 61 patients with severe hepatitis and toxic enteroparalysis were randomly assigned to three groups. The first group was treated with plasmaphe...

Original articles_Viral hepatitis
Clinical features and liver pathology in chronic hepatitis B virus-infected patients with normal liver function
Chen Li, Zhou XingBei, Wen DanFeng, Wu XueJun, Yang LiJun, Sun Li, Tan YouWen
2015, 31(9): 1430-1433. DOI: 10.3969/j.issn.1001-5256.2015.09.016
Abstract:

Objective To study the clinical features and liver pathology in chronic hepatitis B( HBV)-infected patients with normal liver function,and to explore the influencing factors. Methods A total of 316 chronic HBV-infected patients with normal liver function who were admitted to our hospital from August...

Causes and countermeasures for relapse after drug withdrawal in patients with chronic hepatitis C
Zhang YueRong, Zhou Ning, Li XiangLin, Wu LiYang, Wei ShiFang, Zhang YaoDi, Zhang YuePing
2015, 31(9): 1434-1438. DOI: 10.3969/j.issn.1001-5256.2015.09.017
Abstract:

Objective To study the causes and influential factors for relapse after drug withdrawal in patients with chronic hepatitis C( CHC). Methods One hundred and one cases of CHC,including 36 males and 65 females,who were outpatients or inpatients in our hospital,were enrolled as subjects. Twenty-six pati...

Original articles_Liver fibrosis and liver cirrhosis
Effects of Helicobacter pylori infection on common lethal factors for hepatitis B virus-related cirrhosis
Li YuLing, Dan ZhengFei, Shi Lei, Duan ZhiJun
2015, 31(9): 1439-1443. DOI: 10.3969/j.issn.1001-5256.2015.09.018
Abstract:

Objective To study the relationship between Helicobacter pylori( H. pylori) infection and common lethal factors for hepatitis B virus-related cirrhosis( HBC). Methods A total of 235 patients with HBC who were admitted to our hospitals from October 2008 to October 2014 were retrospectively analyzed. ...

Application of Monse′s solution in bleeding in endoscopic sclerotherapy for esophageal varices
Dong Lin, Li HongLiang, Ye ZhengCai, Guo RuiFang
2015, 31(9): 1444-1446. DOI: 10.3969/j.issn.1001-5256.2015.09.019
Abstract:

Objective To investigate the effects of Monsel's solution on bleeding in endoscopic sclerotherapy for esophageal varices. Methods One hundred and sixteen patients with cirrhosis and esophageal variceal bleeding who were admitted to our hospital from February 2013 to February 2015 were enrolled as su...

Changes in T lymphocyte subsets and cytokines in peripheral blood of patients with primary biliary cirrhosis after treatment with different doses of ursodeoxycholic acid
Shi GuangYing, Ma XiaoYuan, Xie JingDong
2015, 31(9): 1447-1451. DOI: 10.3969/j.issn.1001-5256.2015.09.020
Abstract:

Objective To investigate the immunological improvement effects of different doses of ursodeoxycholic acid( UDCA) on patients with different stages of primary biliary cirrhosis( PBC) and enhance the understanding of the roles of the immune system in the disease,and to provide evidence for the standar...

Original articles_Liver neoplasms
Expression and correlation analysis of γ-glutamyl transpeptidase and alpha-fetoprotein in patients with hepatocellular carcinoma
Bai LiQing, Qiao JiaNi
2015, 31(9): 1452-1454. DOI: 10.3969/j.issn.1001-5256.2015.09.021
Abstract:

Objective To analyze the expression levels of γ-glutamyl transpeptidase( GGT) and alpha-fetoprotein( AFP) and their correlation in patients with hepatocellular carcinoma( HCC) and to evaluate their diagnostic values for HCC. Methods A total of 160 patients consisting of 84 cases of HCC and 76 cases ...

Analysis of prognostic factors for patients treated by radical resection of liver metastases from colorectal cancer
Zhang ZhiQuan
2015, 31(9): 1455-1457. DOI: 10.3969/j.issn.1001-5256.2015.09.022
Abstract:

Objective To explore the prognostic factors for patients treated by radical resection of the liver metastases from colorectal cancer and to analyze the significance of these factors. Methods The clinical and pathological data concerning 182 patients with liver metastases from colorectal cancer,who w...

Effects of 5-fluorouracil on biological characteristics and drug resistance mechanisms of liver cancer cell line PLC/RAF/5
Cheng KangWen, Li Qi, Zhan YongQiang, Wang ChengYou, Wang GuiHe, Ni Yong, Zhu BaoHe, Deng XueSong
2015, 31(9): 1458-1463. DOI: 10.3969/j.issn.1001-5256.2015.09.023
Abstract:

Objective To study the changes in biological characteristics of a liver cancer cell line PLC / RAF /5 after repeated exposure to a chemotherapy drug,5-fluorouraci( 5-FU),and to investigate the relationship between drug-resistant liver cancer cells and liver cancer stem cells. Methods A low concentra...

Original articles_Pancreatic diseases
Somatostatin and its analogues combined with proton pump inhibitor in prevention of post-ERCP pancreatitis: a meta-analysis
Liu Chao, Zhang Lei
2015, 31(9): 1464-1468. DOI: 10.3969/j.issn.1001-5256.2015.09.024
Abstract:

Objective To systematically evaluate the clinical efficacy of somatostatin and its analogues combined with proton pump inhibitor in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography( ERCP) by an evidence-based medicine approach.Methods Articles were searched manuall...

Original articles_Others
Diagnostic values of plasma Golgi protein-73 and platelet count for different stages of HBV-related liver diseases
Liu XiuHong, Zhao YiMing, Li Ning, Jin BoXun, Yan HuiPing, Zhao YuanShun, Li Ang, Han Zhen, Zhang AiYing
2015, 31(9): 1469-1472. DOI: 10.3969/j.issn.1001-5256.2015.09.025
Abstract:

Objective To determine the Golgi protein-73( GP73) level and platelet( PLT) count in the peripheral blood of patients with hepatitis B virus( HBV)-related liver diseases and to investigate their values in diagnosing different stages of HBV-related liver diseases.Methods Peripheral blood samples were...

Clinical characteristics of autoimmune hepatitis: an analysis of 194 patients
Deng YongJun, Xiao MingZhong, Li XiaoDong, Le FengHua, Ni Wei
2015, 31(9): 1473-1476. DOI: 10.3969/j.issn.1001-5256.2015.09.026
Abstract:

Objective To investigate the main clinical characteristics of patients with autoimmune hepatitis( AIH). Methods An analysis was performed on the data of 194 AIH patients who visited Guanggu Branch of Hubei Provincial Hospital of Traditional Chinese Medicine from December 2010 to December 2014 and 19...

Impact of high-altitude exposure on hepatic gluconeogenesis in rats
Ni Qian, Wan FengQi, Dong XiangYu, Zhang YouCheng
2015, 31(9): 1477-1480. DOI: 10.3969/j.issn.1001-5256.2015.09.027
Abstract:

Objective To study the effect of high altitude( HA) of 4300 m on the hepatic gluconeogenesis in rats and its underlying mechanism. Methods Thirty-six healthy adult male Sprague-Dawley( SD) rats were randomly assigned to group H1( HA exposure for 1 day,n = 6),group H3( HA exposure for 3 days,n = 6),g...

Brief reports
Experience in diagnosis and treatment of hepatic tuberculosis with hepatic space-occupying lesions: a report of 4 cases
Li WeiNan, Peng CiJun, Yang Gang, Li XiongXiong, Mei Yong, Shu DeJun
2015, 31(9): 1481-1482. DOI: 10.3969/j.issn.1001-5256.2015.09.028
Abstract:
Case reports
Acute liver failure caused by antitubercular drugs: a report of one case
Shen ShuiYing, Wu Jun
2015, 31(9): 1483-1484. DOI: 10.3969/j.issn.1001-5256.2015.09.029
Abstract:
Interferon-induced adverse reaction of fingernail (toenail) damage: a report of four cases
Wang JingBo, Zhao XiuHong, Cui ShiYu, Li XiaoYing
2015, 31(9): 1485-1487. DOI: 10.3969/j.issn.1001-5256.2015.09.030
Abstract:
Severe liver damage caused by chronic active Epstein-Barr virus infection in children: a report of one case
Tian ZongSheng, Wen XiaoYu, Wang ZhongYang, Li MingXian, Jin QingLong
2015, 31(9): 1488-1489. DOI: 10.3969/j.issn.1001-5256.2015.09.031
Abstract:
Systemic amyloidosis: a report of one case
Li GuangMing, Xu XiangTao, Qiao Fei
2015, 31(9): 1490-1491. DOI: 10.3969/j.issn.1001-5256.2015.09.032
Abstract:
IgG4-related sclerosing cholangitis: a  report of one case
Zhang WenWen, Fan YongGang
2015, 31(9): 1492-1493. DOI: 10.3969/j.issn.1001-5256.2015.09.033
Abstract:
Cavernous transformation of the portal vein after splenectomy: a report of one case
Wang ChaoYang, Ren JianZhuang, Han XinWei
2015, 31(9): 1494-1495. DOI: 10.3969/j.issn.1001-5256.2015.08.034
Abstract:
Reviews
Research advances in new approaches to treatment of acute-on-chronic liver failure
Liu Hong, Chen Gang, Gan XueMei
2015, 31(9): 1496-1500. DOI: 10.3969/j.issn.1001-5256.2015.09.035
Abstract:

Acute-on-chronic liver failure( ACLF),a severe hepatic syndrome,is the most common type of hepatic failure in China,which has no specific treatment until now. Traditional therapies mainly include comprehensive medical treatment,artificial liver support system( ALSS),and liver transplantation. In rec...

Research advances in acute-on-chronic liver failure
Jiang ChengZhi, Yan XiZhang
2015, 31(9): 1501-1504. DOI: 10.3969/j.issn.1001-5256.2015.09.036
Abstract:

Acute-on-chronic liver failure( ACLF) is a severe liver disease with high mortality in China. Early diagnosis could reduce complications and improve the survival rate. In the present review,the definition,etiology,and pathogenesis related to inflammatory response,reactive oxygen species,and metaboli...

Mechanism of treatment of acute-on-chronic liver failure with mesenchyaml stem cells
Ma LinJie, Chen Gang, Hu ZongQiang, Liu Hong, Wang DongDong, Fang He, Jin Xiong
2015, 31(9): 1505-1508. DOI: 10.3969/j.issn.1001-5256.2015.09.037
Abstract:

Liver diseases are common in China. When the diseases progress to the end stage,liver transplantation has been considered as the most effective means of treatment. Whereas,due to the causes such as lack of donors,the treatment of acute-on-chronic liver failure has been restricted. While stem cells,e...

Research advances in liver failure of unknown etiology
Zhu Bing, Liu WanShu, You ShaoLi
2015, 31(9): 1509-1512. DOI: 10.3969/j.issn.1001-5256.2015.09.038
Abstract:

A high proportion of the causes of liver failure remain unknown. This paper reviews the progress in the epidemiology,etiology,treatment,and prognosis of liver failure of unknown etiology. The possible causes of liver failure of unknown etiology may include occult hepatitis B virus infection,herpesvi...

Research progress in combination therapy with pegylated interferon and nucleos(t)ide analogues in treatment of chronic hepatitis B
Yu YiQi, Chen ShaoLong, Zhang WenHong
2015, 31(9): 1513-1519. DOI: 10.3969/j.issn.1001-5256.2015.09.039
Abstract:

Current antiviral treatment strategy for chronic hepatitis B( CHB) includes pegylated interferon( PEG-IFN) and nucleos( t) ide analogues( NAs). Whether combination therapy with PEG-IFN and NAs improve therapeutic efficacy has become the key question regarding the antiviral therapy for CHB. This arti...

Research advances in therapeutic strategies against covalently closed circular DNA of hepatitis B virus
Li Qiang, Zhuo QiBin, Huang YuXian, Chen Liang
2015, 31(9): 1520-1523. DOI: 10.3969/j.issn.1001-5256.2015.09.040
Abstract:

Chronic infection with hepatitis B virus( HBV) often leads to the development of liver cirrhosis and liver cancer,creating immense sociological,clinical,and economic burdens worldwide. Although current anti-HBV drugs can control the disease progression,they often fail to eliminate the virus because ...

New advances in tree shrew model in experimental studies of hepatitis B virus
Jin Xiong, Li Li
2015, 31(9): 1524-1527. DOI: 10.3969/j.issn.1001-5256.2015.09.041
Abstract:

Hepatitis B virus( HBV) infection is the main cause of liver fibrosis,cirrhosis,and hepatocellular carcinoma,and it is also a major health problem around the world. How to establish an efficient,reliable,and standardized animal model of chronic HBV infection is essential to the study of the pathogen...

Embolization of spontaneous portosystemic shunt for cirrhotic patients with portal hypertension: a review of current status
Wu WenBin, Han GuoHong
2015, 31(9): 1528-1531. DOI: 10.3969/j.issn.1001-5256.2015.09.042
Abstract:

Spontaneous portosystemic shunt( SPSS) has not yet drawn enough attention. The incidence of SPSS in cirrhotic patients is 38%-40%,and 46%-70% of cirrhotic patients with refractory encephalopathy show SPSS. Embolization of SPSS may be a safe and effective method for the treatment of refractory enceph...

Research advances in immune cellular pathogenesis in liver fibrosis
Xiao ChunYang, Lu LunGen
2015, 31(9): 1532-1536. DOI: 10.3969/j.issn.1001-5256.2015.09.043
Abstract:

Liver fibrosis is the common pathological consequence of all chronic liver diseases with various etiologies. The mechanism of liver fibrosis is associated with the activation and proliferation of hepatic stellate cells( HSCs). The interaction between immune cells and HSCs can regulate the production...

Role of endoplasmic reticulum stress-mediated apoptosis in liver fibrosis
Zhang Xu, Wang Yu, Ma Juan, Wang ZhenZhen, Yuan Juan, Ma Yan, Liu Xin
2015, 31(9): 1537-1539. DOI: 10.3969/j.issn.1001-5256.2015.09.044
Abstract:

Recent studies have found that endoplasmic reticulum stress( ERS) is a common feature of the pathogenesis of organ fibrosis.However,the functional alteration of ERS and its potential role in the process of liver fibrosis is still unclear. This review summarizes the potential function of ERS and ERS-...

Role of Wnt signaling pathway in progression of liver cirrhosis
Zhou XueLing, Yu ShuiPing
2015, 31(9): 1540-1542. DOI: 10.3969/j.issn.1001-5256.2015.09.045
Abstract:

In the past,liver cirrhosis was thought to be irreversible. However,theoretically,the process of liver cirrhosis could be slowed down by inhibiting extracellular matrix( ECM) production and by promoting its degradation. Wnt signaling pathway has been involved in many physiological and pathological p...

Evaluation of abnormal liver function and its clinical significance
Li Fei, Lu LunGen
2015, 31(9): 1543-1546. DOI: 10.3969/j.issn.1001-5256.2015.09.046
Abstract:

Abnormal liver function is biochemical and pathological changes in the liver caused by damages from pathogens,which can be found in viral hepatitis,fatty liver,alcoholic liver diseases,autoimmune liver diseases,and some non-liver diseases. Due to the diversity in etiology,it is difficult to make a d...

Research advances in pathological and imaging manifestations of hepatic nodular lesions
He LingLing, Zhao YaLin, Du LinLin, Zhang Ke, Du HongBo, Jiang YuYong, Yang ZhiYun
2015, 31(9): 1547-1550. DOI: 10.3969/j.issn.1001-5256.2015.09.047
Abstract:

The hepatic nodular lesions in the progression of various chronic liver diseases are hot topics all the time. There is a close relationship between hepatic nodular lesions and hepatocellular carcinoma( HCC),and the former is the precancerous lesions of the latter. This paper summarizes the pathologi...

Cause and prevention of pleural effusion after liver resection
Shi YueFeng, Shao YingMei
2015, 31(9): 1551-1553. DOI: 10.3969/j.issn.1001-5256.2015.09.048
Abstract:

Liver resection is the main method of treatment of hepatic space-occupying lesion,and pleural effusion is one of the common complications. With the technological development in recent years,this paper analyzes the pleural effusion after liver resection from the aspects of hypoproteinemia,diaphragm d...

Expression and significance of classical ACE-AngII-AT1 axis and new ACE2-Ang (1-7)-Mas axis of renin-angiotensin system in local pancreas
Liu XiaoYa, Liu RuiXia, Yin ChengHong
2015, 31(9): 1554-1557. DOI: 10.3969/j.issn.1001-5256.2015.09.049
Abstract:

The renin-angiotensin system( RAS) is a classical circulating enzyme pathway that plays an important role in regulation of pancreatic function. In recent years,with deepening understanding of RAS,researchers found that RAS not only includes the classical ACE-Ang II-AT1 axis,but also includes the new...